Epigenetic Therapy

Epigenetic therapy is the use of drugs or other epigenome-influencing techniques to treat medical conditions such as cancer, heart disease, diabetes, and mental illnesses. Epigenetic therapies are among the most active areas of preclinical and clinical cancer research evidence to their potential of specifically targeting chromatin-mediated disease mechanisms. It is expected that these therapies will have fewer side effects than conventional cytotoxic chemotherapies. Several classes of drugs have emerged, and several are on-going development.

The DNMT inhibitors 5-azacytidine and 5-aza-20-deoxycytidine have both been approved by the FDA for the treatment of various forms of cancer. These drugs have been evident to reactivate the cellular antitumor systems which are repressed by cancer, hence enabling the body to weaken the tumor.

    Related Conference of Epigenetic Therapy

    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France

    Epigenetic Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in